Catalyst Wire Dossier Catalyst Wire Dossier

Clindamycin Phosphate 1.2%

clindamycin phosphate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clindamycin Phosphate 1.2%, covering 2012-06-15 to 2012-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea [Phase 2, Phase 3]

See pricing